The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with retinitis pigmentosa. Clinical stage biopharmaceutical company Nacuity ...

Clinical stage biopharmaceutical company Nacuity Pharmaceuticals announced that the US FDA has granted Fast Track designation for its NPI-001 (N-acetylcysteine amide) tablets, a proprietary ...

NPI-001 is a proprietary, GMP-grade formulation of N-acetylcysteine amide (NACA) tablets being developed to target oxidative stress associated with diseases such as retinitis pigmentosa.

NEW YORK, Jan. 20, 2025 /PRNewswire/ -- The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024 to 2028, according to Technavio. The market is estimated to grow ...

Repeated doses of paracetamol in older patients can lead to an increased risk of several severe complications, researchers have reported. An analysis of 20 years of GP data found an increased risk of ...

a TechRadar favorite The UP6 has a 10GbE Ethernet Interface and two TB4 ports to deliver up to 8GBps speeds It is thought to be the first portable AI tablet NAS (because it has a touchscreen ...

The Xiaomi Pad 7 is a productivity-focused tablet powered by the Qualcomm Snapdragon 7 Plus Gen 3 system-on-chip. It runs the Android 15-based HyperOS 2, featuring tablet-specific enhancements ...

Large tablets often feel large and unwieldy, but some manufacturers have taken this into consideration by combining lightweight designs with premium materials and excellent viewing angles.

Analysis of ratios of trough values on Days 2, 3 and 4 found that a steady state was reached for both ibuprofen and paracetamol and no accumulation of either ibuprofen or paracetamol was evident ...